Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| capsule, gelatin coated | 3 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| nextsource biotechnology, llc | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Gleostine | lomustine | capsule, gelatin coated, oral | 58181-3040NDA |
| Gleostine | lomustine | capsule, gelatin coated, oral | 58181-3041NDA |
| Gleostine | lomustine | capsule, gelatin coated, oral | 58181-3042NDA |
Compare
Other companies listing lomustine
- Azurity Pharmaceuticals, Inc.0 sites · 61 NDC
- Wilshire Pharmaceuticals, Inc.0 sites · 48 NDC
Enquiry
Common questions
- Is NextSource Biotechnology, LLC FDA approved?
- NextSource Biotechnology, LLC holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does NextSource Biotechnology, LLC make?
- 3 products are listed under NextSource Biotechnology, LLC in the openFDA NDC Directory, most often as capsule, gelatin coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.